Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Again, keep them protected from light
The introduction of an injectable GLP-1 has opened up new possibilities for patients with type 2 diabetes and obesity
A study comparing adherence between people with T2D that use insulin and those using GLP-1s found that insulin users had an adherence level of around 90% compared with around 74% for those using GLP-1s (both oral and injectable versions).9 For those using GLP-1s for weight loss, injections are a choice
Gastrointestinal adverse effects were the most commonly reported side effects
People experiencing significant GI side effects that might cause dehydration
Rotate injection sites to avoid reactions
US$ 28.73
:max_bytes(150000):strip_icc():focal(548x269:550x271)/zepbound-122624-tout-ba1f79ab6ac94b798d24d457d105be03.jpg)
US$ 25.87
US$ 20.69
